EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

What every clinician needs to know about chronic kidney disease: Detection, classification and epidemiology

Nicholas M Selby iD, Maarten W Taal

Diabetes, Obesity and Metabolism · 2024-11 · 26 (S6) · 3-12

DOI: 10.1111/dom.15683 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 28.05.2024. Verfasst von Nicholas M Selby und 1 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Kidney Research and Innovation, Academic Unit of Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham,…. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Glomerular Filtration Rate. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease (CKD) is a major healthcare challenge, affecting >800 million people worldwide. Implications for population health result from the strong associations of CKD with increased rates of cardiovascular disease, heart failure, progressive CKD leading to kidney failure, acute kidney injury (AKI), and mortality. In addition to a single disease perspective, CKD commonly coexists alongside other long‐term conditions, in particular type 2 diabetes and cardiovascular disease. CKD is therefore an important component of multimorbidity that influences individual management and impacts prognosis. CKD is defined by abnormalities of kidney structure or function of any cause with implications for health that are present for longer than 3 months. The diagnosis is usually made on the basis of an abnormal glomerular filtration rate (GFR < 60 mL/min/1.73 m 2 ) and/or the presence of proteinuria (urine albumin to creatinine ratio > 30 mg/g or >3 mg/mmol). GFR is usually estimated from serum creatinine concentration using a variety of validated equations. However, serum creatinine is closely related to muscle mass and may therefore not be an accurate marker of GFR in people with high or low muscle mass (sarcopaenia). Cystatin C is an alternative endogenous marker of GFR that is increasingly being used but also has limitations. An estimate of GFR based on both creatinine and cystatin C is the most accurate. Diagnosis should be followed by classification and risk stratification to guide the development of a risk‐based, personalized care plan. Improved detection and widespread implementation of optimal CKD management has the potential to bring major benefits to population health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicGlomerular Filtration RateHumansCystatin CBiomarkersCreatinineDiabetes Mellitus, Type 2Cardiovascular DiseasesProteinuria

Stichwörter der Autor:innen

SGLT2 inhibitorcardiovascular diseasediabetes complicationsdiabetic nephropathy

Substanzen

Cystatin CBiomarkersCreatinine

Autor:innen und Institutionen

  • Centre for Kidney Research and Innovation, Academic Unit of Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK.
  • Department of Renal Medicine, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK.

ORCID-Profile: Nicholas M Selby

Zitieren

APA

Selby, N. M., & Taal, M. W. (2024). What every clinician needs to know about chronic kidney disease: Detection, classification and epidemiology. Diabetes, Obesity and Metabolism, 26(S6), 3-12. https://doi.org/10.1111/dom.15683

Vancouver

Selby NM, Taal MW. What every clinician needs to know about chronic kidney disease: Detection, classification and epidemiology. Diabetes, Obesity and Metabolism. 2024;26(S6):3-12. doi:10.1111/dom.15683

BibTeX
@article{Selby2024,
  author = {Selby, Nicholas M and Taal, Maarten W},
  title = {What every clinician needs to know about chronic kidney disease: Detection, classification and epidemiology},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2024},
  volume = {26},
  number = {S6},
  pages = {3--12},
  doi = {10.1111/dom.15683}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche